Sanyou Biopharmaceuticals introduces Clicklinks, an AI-powered platform revolutionizing original drug discovery and development processes.

SHANGHAI, Aug. 28, 2026 /PRNewswire/ -- Sanyou Biopharmaceuticals Co., Ltd. (hereinafter referred to as "Sanyou Bio"), today announced the official launch of Clicklinks, an AI-STAL and SAI-DA powered collaborative network designed to support original drug discovery and preclinical...

SHANGHAI, May 23, 2026 /PRNewswire/ — For many participants in the innovative drug discovery arena, AI-STAL and SAI-DA are already familiar names within the Sanyou Bio ecosystem. AI-STAL is recognized as the “Grand Master Librarian” safeguarding a Super Trillion Antibody Library, while SAI-DA is regarded as the “White Knight” accelerating drug development with AI-driven efficiency. Today, […]

Discover how Clicklinks, the latest platform under Sanyou Bio, is revolutionizing drug discovery by connecting innovators globally and streamlining processes.

SHANGHAI, May 23, 2026 /PRNewswire/ -- For many participants in the innovative drug discovery arena, AI-STAL and SAI-DA are already familiar names within the Sanyou Bio ecosystem. AI-STAL is recognized as the "Grand Master Librarian" safeguarding a Super Trillion Antibody Library, while...

SHANGHAI, April 15, 2026 /PRNewswire/ -- 01 Introduction In the race of innovative drug R&D, whether for antibodies, peptides, or novel binding proteins, the efficiency of early-stage molecule discovery is always the key factor determining project success or failure. However, traditional...